Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro-Reference-Cited by-同舟云学术

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro

Published:2024-02 Issue: Volume:220 Page:115981
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Hurrish Katie H.,Su Yongwei,Patel Shraddha,Ramage Cassandra L.,Zhao Jianlei,Temby Brianna R.,Carter Jenna L.,Edwards Holly,Buck Steven A.,Wiley Sandra E.,Hüttemann Maik,Polin Lisa,Kushner Juiwanna,Dzinic Sijana H.,White Kathryn,Bao Xun,Li Jing,Yang Jay,Boerner Julie,Hou Zhanjun,Al-Atrash Gheath,Konoplev Sergej N.,Busquets Jonathan,Tiziani Stefano,Matherly Larry H.,Taub Jeffrey W.,Konopleva Marina,Ge Yubin^ORCID,Baran Natalia

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference62 articles.

1. Tracing the origins of relapse in acute myeloid leukaemia to stem cells;Shlush;Nature.,2017

2. Treatment of Relapsed/Refractory Acute Myeloid Leukemia;Bose;Curr Treat Options Oncol.,2017

3. Evaluating venetoclax and its potential in treatment-naive acute myeloid leukemia;Knight;Cancer Manag Res.,2019

4. Venetoclax for AML: changing the treatment paradigm;Pollyea;Blood Adv.,2019

5. Targeting Apoptosis in Acute Myeloid Leukemia: Current Status and Future Directions of BCL-2 Inhibition with Venetoclax and Beyond;Choi;Target Oncol.,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Interplay between Autophagy and Mitochondria in Cancer;International Journal of Molecular Sciences;2024-08-23

2. Mitohormesis : la clé de voûte de la résistance thérapeutique des cellules cancéreuses;Comptes Rendus. Biologies;2024-08-22

3. Venetoclax: a new player in the treatment of children with high-risk myeloid malignancies?;Blood Advances;2024-07-09

4. Can O-GIcNAc Transferase (OGT) Complex Be Used as a Target for the Treatment of Hematological Malignancies?;Pharmaceuticals;2024-05-22

5. Inhibition of purine metabolism promotes the differentiation of the neuroblastoma driven by MYCN;2024-02-29